Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Acquiror's Counsel

INVESTCORP ACQUIRES CAMBIO HEALTHCARE SYSTEMS

20 Feb 2019

Shearman & Sterling represented Investcorp in connection with its agreement to acquire a majority interest in Cambio Healthcare Systems from Valedo Partners Fund II AB and a group of minority investors.

Investcorp was founded in 1982 and is today a leading global investment company with 390 employees in Europe and worldwide. The company focuses on investment opportunities in medium-sized companies with strong management, sound finances, leading positions in their sector and good growth potential.

LATHAM ADVISES HELLMAN & FRIEDMAN AND BLACKSTONE ON THE ACQUISITION OF SCOUT24

18 Feb 2019

Transaction represents the largest-ever public-to-private deal in Germany.

Pulver BidCo GmbH, a holding company jointly controlled by funds advised by Hellman & Friedman LLC and affiliates of The Blackstone Group L.P., has announced its decision to make a voluntary public tender offer to the shareholders of Scout24 AG. Under the terms and conditions of the voluntary public tender offer, Scout24's shareholders will receive EU46.00 per share in cash. This puts a total equity value of EU4.9 billion and a total enterprise value of EU5.7 billion on the Company.

Blackstone to Acquire 50% of Taubman Interests in Three Asia Shopping Centers

16 Feb 2019

The Firm is representing Blackstone in its acquisition of 50% of Taubman Asia’s interests in three Asia-based shopping centers – Starfield Hanam, CityOn.Xi’an and CityOn.Zhengzhou (located in Hanam, South Korea; Xi’an, China; and Zhengzhou, China, respectively). Taubman Asia is a subsidiary of Taubman Centers, Inc. (NYSE: TCO), an S&P MidCap 400 Real Estate Investment Trust engaged in the ownership, management and/or leasing of 26 regional, super-regional and outlet shopping centers in the U.S. and Asia and one under development.

CITOXLAB TO BE ACQUIRED BY CHARLES RIVER LABORATORIES FOR €448 MILLION

16 Feb 2019

The Paris Private Equity team advised the shareholders of Citoxlab on granting an exclusivity to Charles River Laboratories International, Inc. in consideration for a binding offer of €448 million in cash (or approximately $510 million) for the acquisition of Citoxlab. The proposed transaction is subject to labor consultations, regulatory requirements, and customary closing conditions. Upon completion of the labor consultations, Citoxlab’s shareholders are expected to enter into a definitive purchase agreement.